Diffuse Large B-cell Lymphoma (March 2016): Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 55-year-old female who presented with several weeks history of progressive left cervical adenopathy. The patient FNA suggested high grade neoplasm and excisional biopsy was recommended. A left cervical LN excisional biopsy showed a lymphoid malignancy comprised of large cells with moderate amounts of cytoplasm. The neoplastic cells had vesicular chromatin and prominent nucleoli. Mitotic figures were numerous.

Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, completion, or participation certificates for completing this activity. 

Learning Objectives:

  • Recognize molecular subtypes of DLBCL and expected outcomes of these
  • Evaluate currently available molecular work up of patients with newly diagnosed DLBCL and methods of molecular subtype classification 
  • Discuss how molecular subtype of DLBCL drives selection of therapy, including ongoing clinical studies landscape 

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on March 30, 2019. Participants must complete all necessary course components by this date to receive credit.